These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 25692121)
1. Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients. Song SH; Kim MS; Lee JJ; Ju MK; Lee JG; Lee J; Choi JS; Choi GH; Kim SI; Joo DJ Ann Surg Treat Res; 2015 Feb; 88(2):100-5. PubMed ID: 25692121 [TBL] [Abstract][Full Text] [Related]
2. Preformed donor-specific antibodies are associated with 90-day mortality in living-donor liver transplantation. Tamura K; Tohyama T; Watanabe J; Nakamura T; Ueno Y; Inoue H; Honjo M; Sakamoto K; Takai A; Ogawa K; Takada Y Hepatol Res; 2019 Aug; 49(8):929-941. PubMed ID: 30991451 [TBL] [Abstract][Full Text] [Related]
3. Preformed donor-specific antibodies do not affect the 1-year allograft survival in living donor liver transplantation. Kim H; Yi NJ; Song EY; Lee K; Lee KW; Lee HW; Ahn HY; Yoon KC; Hong SK; Suh KS Clin Transplant; 2018 May; 32(5):e13244. PubMed ID: 29577436 [TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of donor-specific human leukocyte antigen antibodies after pediatric liver transplantation. Liu W; Wang K; Xiao YL; Liu C; Gao W; Li DH Exp Ther Med; 2021 Aug; 22(2):867. PubMed ID: 34194545 [TBL] [Abstract][Full Text] [Related]
5. The fate of anti-HLA antibodies following liver transplantation. Norman DJ; Enestvedt CK; Naugler WE; Erhan R; Shaut CA Front Nephrol; 2024; 4():1403096. PubMed ID: 38933742 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients. Korean J Transplant; ; . PubMed ID: 35769408 [TBL] [Abstract][Full Text] [Related]